Outlines recombinant glycoprotein expression in different host systems

Discusses the role of glycosylation on protein function and vaccine development

Updates on cutting edge glycoanalytical technologies 

Sets out future directions in glycobiotechnology and glycoanalysis

Dr. Erdmann Rapp is heading the Bio/Process Analytics team of the Bioprocess Engineering Department at the Max Planck Institute for Dynamics of Complex Technical Systems in Magdeburg and founder, CEO & CSO of glyXera, providing tailored cutting-edge glycoanalytical products and services. He is an experienced researcher, inventor, mentor and university lecturer. He and his team are working on the development and implementation of innovative bio/process analytics - in particular, on sophisticated tools for proteomics, glycoproteomics and glycomics - for a deeper understanding of biological and biotechnological processes. Dr. Rapp’s successful research is documented by more than 120 peer-reviewed papers and book chapters, and 8 patents.